← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mti Biotech, Inc.
Ames, IA
$4,350,682
Total funding
4
Grants
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,350,682 · 4
By mechanism
R42$3,088,886 · 1
R41$656,580 · 2
R44$605,216 · 1
Investigators at Mti Biotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
2-HOBA for Treatment of Pulmonary Hypertension$1,173,060
R42 · FY2023 · HL
2-HOBA for Treatment of Pulmonary Hypertension$957,913
R42 · FY2025 · HL
2-HOBA for Treatment of Pulmonary Hypertension$957,913
R42 · FY2024 · HL
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$605,216
R44 · FY2017 · AG
Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis$400,000
R41 · FY2021 · CA
2-HOBA for Treatment of Pulmonary Hypertension$256,580
R41 · FY2021 · HL